Clinical Trial Update: Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating MK-0752 in combination with tamoxifen or letrozole for early-stage breast cancer has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• MK-0752
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Loyola University | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2019-09-04